Bluefin Capital Management’s Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 LLAP.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-16,823
Closed -$9K 726
2022
Q2
$9K Sell
16,823
-60,667
-78% -$29.4K ﹤0.01% 498
2022
Q1
$38K Buy
+77,490
New +$45.3K ﹤0.01% 485

Other funds holding LLAP.WS

Bluefin Capital Management's LLAP.WS Position: Q3 2022 in Review

Bluefin Capital Management sold out of Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 (LLAP.WS) in Q3 2022, closing a stake of 16,823 shares — an estimated $9K sold.

Bluefin Capital Management first reported a position in LLAP.WS in Q1 2022 and held it in 2 quarters. The position peaked at $38K in Q1 2022. 32 funds tracked by Wall St. Rank hold LLAP.WS as of Q3 2022.

  • Bluefin Capital Management reported no remaining Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 16,823 Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 shares in Q3 2022, an estimated $9K.
  • Bluefin Capital Management first reported a position in Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 in Q1 2022 and held it in 2 quarters.
  • Bluefin Capital Management's Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 position peaked at $38K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Terran Orbital Corporation Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 as of Q3 2022.

Based on Bluefin Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.